BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 19937818)

  • 1. In silico pKa prediction and ADME profiling.
    Cruciani G; Milletti F; Storchi L; Sforna G; Goracci L
    Chem Biodivers; 2009 Nov; 6(11):1812-21. PubMed ID: 19937818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico prediction of ionization constants of drugs.
    Lee PH; Ayyampalayam SN; Carreira LA; Shalaeva M; Bhattachar S; Coselmon R; Poole S; Gifford E; Lombardo F
    Mol Pharm; 2007; 4(4):498-512. PubMed ID: 17629304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting ADME properties and side effects: the BioPrint approach.
    Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New and original pKa prediction method using grid molecular interaction fields.
    Milletti F; Storchi L; Sforna G; Cruciani G
    J Chem Inf Model; 2007; 47(6):2172-81. PubMed ID: 17910431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico prediction of ADME properties: are we making progress?
    Beresford AP; Segall M; Tarbit MH
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):36-42. PubMed ID: 14982146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of a structurally diverse and commercially available drug data set for correlation and benchmarking studies.
    Sköld C; Winiwarter S; Wernevik J; Bergström F; Engström L; Allen R; Box K; Comer J; Mole J; Hallberg A; Lennernäs H; Lundstedt T; Ungell AL; Karlén A
    J Med Chem; 2006 Nov; 49(23):6660-71. PubMed ID: 17154497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The graphical representation of ADME-related molecule properties for medicinal chemists.
    Ritchie TJ; Ertl P; Lewis R
    Drug Discov Today; 2011 Jan; 16(1-2):65-72. PubMed ID: 21074634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond profiling: using ADMET models to guide decisions.
    Segall M; Champness E; Obrezanova O; Leeding C
    Chem Biodivers; 2009 Nov; 6(11):2144-51. PubMed ID: 19937845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of pH-dependent aqueous solubility of druglike molecules.
    Hansen NT; Kouskoumvekaki I; Jørgensen FS; Brunak S; Jónsdóttir SO
    J Chem Inf Model; 2006; 46(6):2601-9. PubMed ID: 17125200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational determination of aqueous pKa values of protonated benzimidazoles (part 1).
    Brown TN; Mora-Diez N
    J Phys Chem B; 2006 May; 110(18):9270-9. PubMed ID: 16671744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational aqueous solubility prediction for drug-like compounds in congeneric series.
    Du-Cuny L; Huwyler J; Wiese M; Kansy M
    Eur J Med Chem; 2008 Mar; 43(3):501-12. PubMed ID: 17574307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global and local computational models for aqueous solubility prediction of drug-like molecules.
    Bergström CA; Wassvik CM; Norinder U; Luthman K; Artursson P
    J Chem Inf Comput Sci; 2004; 44(4):1477-88. PubMed ID: 15272856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physico-chemical profiling of centrally acting molecules for prediction of pharmacokinetic properties].
    Deák K
    Acta Pharm Hung; 2008; 78(3):110-20. PubMed ID: 18986088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability.
    Cai H; Stoner C; Reddy A; Freiwald S; Smith D; Winters R; Stankovic C; Surendran N
    Int J Pharm; 2006 Feb; 308(1-2):133-9. PubMed ID: 16352407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico ADME modelling 2: computational models to predict human serum albumin binding affinity using ant colony systems.
    Gunturi SB; Narayanan R; Khandelwal A
    Bioorg Med Chem; 2006 Jun; 14(12):4118-29. PubMed ID: 16504519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.
    Dokoumetzidis A; Kalantzi L; Fotaki N
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):491-505. PubMed ID: 17696801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of an ADME enabling selection and visualization tool for drug discovery.
    Stoner CL; Gifford E; Stankovic C; Lepsy CS; Brodfuehrer J; Prasad JV; Surendran N
    J Pharm Sci; 2004 May; 93(5):1131-41. PubMed ID: 15067690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A computational model for the prediction of aqueous solubility that includes crystal packing, intrinsic solubility, and ionization effects.
    Johnson SR; Chen XQ; Murphy D; Gudmundsson O
    Mol Pharm; 2007; 4(4):513-23. PubMed ID: 17539661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.